{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:11:57Z","timestamp":1790115117279,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jacc.2024.07.023","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T08:28:57Z","timestamp":1725265737000},"page":"1528-1540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Heart\u00a0Failure Risk Assessment Using\u00a0Biomarkers in Patients With Atrial\u00a0Fibrillation"],"prefix":"10.1016","volume":"84","author":[{"given":"Paul M.","family":"Haller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Jarolim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Palazzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bellavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott M.","family":"Antman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5169-117X","authenticated-orcid":false,"given":"Josephine","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff S.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Hijazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T.","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Braunwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.07.023_bib1","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics\u20142021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.07.023_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2024.07.023_bib3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jchf.2024.04.010","article-title":"Screening for unrecognized HFpEF in atrial fibrillation and for unrecognized atrial fibrillation in HFpEF","volume":"12","author":"Reddy","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2024.07.023_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.07.023_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrcardio.2015.191","article-title":"Comorbidity of atrial fibrillation and\u00a0heart failure","volume":"13","author":"Ling","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2024.07.023_bib6","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1038\/s41467-024-48229-w","article-title":"Deep learning of left atrial structure and function provides link to atrial fibrillation risk","volume":"15","author":"Pirruccello","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacc.2024.07.023_bib7","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/ejhf.595","article-title":"Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48","volume":"18","author":"Magnani","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.07.023_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004267","article-title":"Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)","volume":"10","author":"Link","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2024.07.023_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacep.2022.11.032","article-title":"Risks of heart failure, stroke, and bleeding in atrial fibrillation according to heart failure phenotypes","volume":"9","author":"Inciardi","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.07.023_bib10","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol."},{"key":"10.1016\/j.jacc.2024.07.023_bib11","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.07.023_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2023.12.033","article-title":"Implications of atrial fibrillation for guideline-directed therapy in patients with heart failure: JACC State-of-the-Art Review","volume":"83","author":"Newman","year":"2024","journal-title":"JACC"},{"key":"10.1016\/j.jacc.2024.07.023_bib13","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.07.023_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.amjcard.2019.07.048","article-title":"Age-dependent prognostic impact of paroxysmal versus sustained atrial fibrillation on the incidence of cardiac death and heart failure hospitalization (the Fushimi AF Registry)","volume":"124","author":"An","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.07.023_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrcardio.2017.48","article-title":"High-sensitivity assays for troponin in patients with cardiac disease","volume":"14","author":"Westermann","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2024.07.023_bib16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ejhf.2844","article-title":"Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation","volume":"25","author":"Oyama","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.07.023_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/eurheartj\/ehac577","article-title":"Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis","volume":"44","author":"Kato","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.07.023_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.07.023_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ahj.2020.12.002","volume":"233","author":"Carnicelli","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.07.023_bib20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.07.023_bib21","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.07.023_bib22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.07.023_bib23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.07.023_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ejhf.3118","article-title":"Natriuretic peptides, body mass index and heart failure risk: pooled analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61","volume":"26","author":"Patel","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.07.023_bib25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1515\/cclm-2014-0565","article-title":"High sensitivity cardiac troponin assays in the clinical laboratories","volume":"53","author":"Jarolim","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacc.2024.07.023_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13253-014-0180-3","article-title":"Characterization of weighted quantile sum regression for highly correlated data in a risk analysis setting","volume":"20","author":"Carrico","year":"2015","journal-title":"J\u00a0Agric Biol Environ Stat"},{"key":"10.1016\/j.jacc.2024.07.023_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1151821","article-title":"A\u00a0weighted quantile sum regression with penalized weights and two indices","volume":"11","author":"Renzetti","year":"2023","journal-title":"Frontiers Public Health"},{"key":"10.1016\/j.jacc.2024.07.023_bib28","doi-asserted-by":"crossref","DOI":"10.1289\/EHP5838","article-title":"A\u00a0quantile-based g-computation approach to addressing the effects of exposure mixtures","volume":"128","author":"Keil","year":"2020","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jacc.2024.07.023_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/ehjcvp\/pvac001","article-title":"SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis","volume":"8","author":"Razuk","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2024.07.023_bib30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jchf.2021.06.017","article-title":"Effects of dapagliflozin in patients with kidney disease, with and without heart failure","volume":"9","author":"McMurray","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2024.07.023_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCULATIONAHA.121.057983","article-title":"Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD Trial","volume":"145","author":"Filippatos","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.07.023_bib32","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.07.023_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/clinchem\/hvaa228","article-title":"Role of cardiac biomarkers in epidemiology and risk outcomes","volume":"67","author":"Haller","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2024.07.023_bib34","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/eurjpc\/zwad122","article-title":"Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus","volume":"30","author":"Haller","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2024.07.023_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/clinchem\/hvaa298","article-title":"Biomarkers for risk assessment in atrial fibrillation","volume":"67","author":"Berg","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2024.07.023_bib36","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2337\/dc21-1170","article-title":"A\u00a0biomarker-based score for risk of hospitalization for heart failure in patients with diabetes","volume":"44","author":"Berg","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2024.07.023_bib37","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/ejhf.2073","article-title":"Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58","volume":"23","author":"Zelniker","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.07.023_bib38","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.2024.5596","article-title":"Prognostic value of cardiovascular biomarkers in the population","volume":"331","author":"Neumann","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.07.023_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.117.031560","article-title":"Prognostic value of high-sensitivity troponin T in chronic heart failure: an individual patient data meta-analysis","volume":"137","author":"Aimo","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.07.023_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ejhf.3078","article-title":"Growth differentiation factor-15 and the effect of empagliflozin in heart failure: findings from the EMPEROR program","volume":"26","author":"Ferreira","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.07.023_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001471","article-title":"Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas","volume":"8","author":"Pol","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2024.07.023_bib42","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/CIRCULATIONAHA.118.038312","article-title":"Performance of the ABC scores for assessing the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48","volume":"139","author":"Berg","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.07.023_bib43","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/ejhf.2887","article-title":"Incremental prognostic value of biomarkers in PARADIGM-HF","volume":"25","author":"McDowell","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.07.023_bib44","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.663","article-title":"Biomarker-based risk prediction in the community","volume":"18","author":"AbouEzzeddine","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.07.023_bib45","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2024.07.023_bib46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/heartjnl-2016-309832","article-title":"Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation","volume":"103","author":"Camm","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.07.023_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/europace\/eux301","article-title":"Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry","volume":"20","author":"Boriani","year":"2018","journal-title":"Europace"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724079658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724079658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T05:16:05Z","timestamp":1760591765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724079658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0735109724079658"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.07.023","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart\u00a0Failure Risk Assessment Using\u00a0Biomarkers in Patients With Atrial\u00a0Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}